Jean-Yves Christophe Chiva

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Novobiotic Pharmaceuticals, LLC. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Yves Christophe Chiva. Retrieved from https://idiyas.com/inventor/jean-yves-christophe-chiva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

5 out of 10

Novobiotic Pharmaceuticals, LLC

patents

Years Active: 2015-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11851458 - Depsipeptide and uses thereof (2023-12-26),

2. 11174290 - Depsipeptide and uses thereof (2021-11-16),

3. 10414800 - Methods for producing a depsipeptide (2019-09-17),

4. 9402878 - Depsipeptide and uses thereof (2016-08-02),

5. 9163065 - Depsipeptide and uses thereof (2015-10-20),

Title: Jean-Yves Christophe Chiva: A Visionary Inventor Shaping the Future

Introduction:

Jean-Yves Christophe Chiva, a visionary inventor based in Ongar, GB, is a prominent figure in the world of innovation. With a passion for pushing the boundaries of technology, Chiva is dedicated to creating solutions that make a lasting impact on society.

Latest Patents:

Chiva has a total of 5 patents to his name, with his latest inventions including "Depsipeptide and uses thereof." This innovation introduces novel depsipeptides and methods for their preparation, pharmaceutical compositions comprising these novel compounds, and methods for treating various disorders.

Career Highlights:

Currently working at Novobiotic Pharmaceuticals, LLC, Chiva channels his inventive spirit into groundbreaking research and development. His contributions to the pharmaceutical industry have been instrumental in advancing treatment options for complex disorders.

Collaborations:

Chiva has collaborated with accomplished professionals in his field, including coworkers Aaron J Peoples and Dallas E Hughes. Together, they have pooled their expertise to drive innovation and develop cutting-edge solutions that address critical healthcare challenges.

Conclusion:

Jean-Yves Christophe Chiva's dedication to innovation and his remarkable contributions to the field of pharmaceuticals underscore his status as a visionary inventor. His commitment to creating solutions that improve the lives of many sets him apart as a standout figure in the world of inventors.

Profile summary based on public USPTO records.